Skip to main content
OpenTrials
Completed

NCT Number: NCT02816697

Implementation of a System-level Tobacco Treatment Intervention

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Health Behavior Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Smoking Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brigham and Women's Hospital, Boston, Massachusetts, United States

Loading trial locations.

About this study

In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients.

  • Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process.
  • Effectiveness of CEASE will be measured through questionnaires & biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18
  • Have an actual or potential diagnosis of thoracic malignancy
  • Able to read and write in English.
  • Current or recent former smoker (defined as having smoked within past 6 months)
  • Must have an active telephone number.

Exclusion criteria

  • Former smoker greater than 6 months.
  • Have any of the below conditions needing immediate medical intervention
  • Hypercalcemia causing lethargy and confusion,
  • Acute respiratory distress
  • Dehydration
  • Hypotension

Treatment and study plan

CEASE

Other
  • Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE)
  • CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits

Usual Care Tobacco Treatment Services

Other

Primary outcomes

  1. Smoking cessation Rate

    Time frame: 6 Months

    Biochemical verification of smoking cessation

Secondary outcomes

  1. Documentation of tobacco treatment

    Time frame: 2 months after CEASE

    Assess documentation of smoking assessment and provision of treatment ( medication and referral for behavioral counseling)

Sponsors and collaborators

Lead sponsor

Dana-Farber Cancer Institute

Other

Collaborators

  • Brigham and Women's Hospital
  • Massachusetts General Hospital

Registry information

Official study title

Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology

Important dates

Study start
2016
Primary completion
2022
Study completion
2026
First posted
Jun 28, 2016
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.